Shareholders in Incyte (NASDAQ:INCY) are in the red if they invested three years ago

For many investors, the main point of stock picking is to generate higher returns than the overall market. But its virtually certain that sometimes you will buy stocks that fall short of the market average returns. Unfortunately, that's been the case for longer term Incyte Corporation (NASDAQ:INCY) shareholders, since the share price is down 23% in the last three years, falling well short of the market return of around 26%. More recently, the share price has dropped a further 17% in a month.

Since shareholders are down over the longer term, lets look at the underlying fundamentals over the that time and see if they've been consistent with returns.

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During the three years that the share price fell, Incyte's earnings per share (EPS) dropped by 66% each year. This fall in the EPS is worse than the 8% compound annual share price fall. So the market may not be too worried about the EPS figure, at the moment -- or it may have previously priced some of the drop in. With a P/E ratio of 363.49, it's fair to say the market sees a brighter future for the business.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

earnings-per-share-growth
NasdaqGS:INCY Earnings Per Share Growth March 27th 2025

This free interactive report on Incyte's earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further.

Advertisement

A Different Perspective

Incyte provided a TSR of 7.2% over the last twelve months. But that return falls short of the market. On the bright side, that's still a gain, and it is certainly better than the yearly loss of about 3% endured over half a decade. It could well be that the business is stabilizing. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 3 warning signs for Incyte you should know about.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:INCY

Incyte

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Outstanding track record with flawless balance sheet.

Advertisement

Weekly Picks

ST
stuart_roberts
UG logo
stuart_roberts on Upside Gold ·

An Undervalued 3.3Moz Gold Project in Canada

Fair Value:CA$5.0775.1% undervalued
121 users have followed this narrative
1 users have commented on this narrative
21 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9822.7% undervalued
39 users have followed this narrative
0 users have commented on this narrative
32 users have liked this narrative
KO
CSL logo
Kouj on CSL ·

CSL: The Dip Is the Opportunity

Fair Value:AU$1559.0% undervalued
16 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative
GA
DHT logo
GavrielH on DHT Holdings ·

DHT Holdings, inc: Strait of Hormuz Risk Amidst US-Israel vs Iran Tensions Spikes VLCC Rates.

Fair Value:US$3653.2% undervalued
12 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative

Updated Narratives

SE
LULU logo
SeanTho on lululemon athletica ·

China Is Growing 46%, The Stock Is Down 47%. Growth and Value Outside the US Market.

Fair Value:US$26540.5% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
MA
INDGN logo
max_profit on Indegene ·

Indegene deep undervalued stock

Fair Value:₹808.9446.9% undervalued
0 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
VE
Vestra
VEON logo
Vestra on VEON ·

VEON Ltd. (VEON): The Frontier "Digital Operator" and the 84% Hypergrowth Inflection

Fair Value:US$67.825.4% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

KA
NU logo
kabz2342 on Nu Holdings ·

Nu holdings will continue to disrupt the South American banking market

Fair Value:US$64.378.4% undervalued
53 users have followed this narrative
3 users have commented on this narrative
27 users have liked this narrative
YA
SOFI logo
Yang_ on SoFi Technologies ·

SoFi Technologies: The Apex Aggregator and the Infrastructure of the Modern Financial System

Fair Value:US$22.9822.7% undervalued
39 users have followed this narrative
0 users have commented on this narrative
32 users have liked this narrative
AN
AnalystConsensusTarget
MSFT logo
AnalystConsensusTarget on Microsoft ·

Analyst Commentary Highlights Microsoft AI Momentum and Upward Valuation Amid Growth and Competitive Risks

Fair Value:US$59633.6% undervalued
1310 users have followed this narrative
2 users have commented on this narrative
10 users have liked this narrative